NL-OMON50372已完成不适用
Acceptance and potential clinical added value of Sense-IT in psychiatric patients with autism spectrum disorder and/or intellectual disability and/or borderline personality disorder: a proof-of-concept study. - Sense-IT in forensic psychiatric patients with ASD and/or ID and/or BPD
niversiteit Twente0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with ASD and/or ID
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •1) is admitted to inpatient care at FPA De Boog, GGNet, Warnsveld
- •2) is diagnosed with ASD and/or ID according to DSM-5 criteria (APA,
- •3) is mentally competent and willing to participate in the study
- •Patients with BPD
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •1) is admitted to inpatient care at Scelta, GGNet, Apeldoorn
- •2) is diagnosed with BPD according to DSM-5 criteria (APA, 2013)
- •3) is mentally competent and willing to participate in the study
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •1) is working at FPA De Boog, GGNet or at Scelta, GGNet
排除标准
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •1) is unable to read, speak or write the Dutch language
- •2) is using beta-blockers, Nurses
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •1) is unable to read, speak or write the Dutch language.
研究者
相似试验
已完成
不适用
Sense-IT in patients with borderline personality disorderBorderline personality disorderNL-OMON21447one10
已完成
不适用
An assessment of the potential clinical utility of a new multiplex-PCR assay (VYOO®) in the management of ICU patients with sepsisDRKS00000612SIRS-Lab GmbH1,050
尚未招募
不适用
Sense-IT in forensic psychiatric patients with ASD and/or IDIntellectual disabilityNL-OMON27963GGNet FPA De Boog in cooperation with Twente University21
尚未招募
2 期
A clinical trial to study the effect of two drugs saptaparna bark and chirabilva bark in patients with Kitibha kushta (psoriasis)CTRI/2022/10/046834Dr.Vinoda Y Sidaraddi
已完成
不适用
Clinical Investigation of Efficacy and Safety in Second-line Bevacizumab treatment combined with FOLFIRI or FOLFOX for metastatic colorectal cancercolorectal cancerJPRN-UMIN000001547Tsukuba Cancer Clinical Trial Group400